SCHEMBL17876007

SCHEMBL17876007

O=S1(=O)Cc2ccc(-c3cc(-c4cccnc4)cc(-c4cccnc4)c3)cc2-c2cc(-c3cccc4oc5ccccc5c34)ccc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.39
TDP2 O95551 2/20 0.39
CYP11B1 P15538 8/20 0.37
CYP11B2 P19099 8/20 0.37
CYP1A2 P05177 3/20 0.37
CYP19A1 P11511 3/20 0.37
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35
LMNA P02545 1/20 0.35
CYP2D6 P10635 1/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
PDE10A Q9Y233 1/20 0.35
NPY5R Q15761 1/20 0.35
PIM1 P11309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875953 0.96 CYP11B1 (0.39) PGRTDP2CYP11B1CYP11B2CYP1A2
SCHEMBL17875967 0.96 CYP11B1 (0.39) PGRTDP2CYP11B1CYP11B2CYP1A2
SCHEMBL17875993 0.89 ALOX5 (0.43) PGRTDP2CYP11B1CYP11B2CYP1A2
SCHEMBL17875997 0.89 CYP19A1 (0.41) PGRTDP2CYP11B1CYP11B2CYP1A2
SCHEMBL17876001 0.89 PGR (0.41) PGRTDP2CYP11B1CYP11B2CYP1A2
SCHEMBL17876004 0.88 PLA2G2A (0.40) CYP19A1CYP3A4MEN1ALDH1A1KMT2A
SCHEMBL17875903 0.87 CYP11B1 (0.39) PGRTDP2CYP11B1CYP11B2CYP1A2
SCHEMBL17876005 0.86 ALOX5 (0.38) CYP3A4CYP2C9CYP2C19MEN1ALDH1A1
SCHEMBL17875962 0.86 ALOX5 (0.40) PGRTDP2CYP11B1CYP11B2CYP1A2
SCHEMBL17875929 0.86 ALOX5 (0.40) PGRTDP2CYP11B1CYP11B2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 PGR 1766/4885TDP2 3979/4885CYP11B1 938/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 PGR 1766/4885TDP2 3979/4885CYP11B1 938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.